Regenerx Biopharmaceuticals Inc (RGRX) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regenerx Biopharmaceuticals inc   (NONE: RGRX)


Regenerx Biopharmaceuticals Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regenerx Biopharmaceuticals Inc's ROI in the first quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Regenerx Biopharmaceuticals Inc 's return on investment (ROI) in its first quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM - -76.61 % -32.33 % 99.53 % 2316.11 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -2 0 0 0 1
Return On Investment (TTM) - - -392.56 % -255.87 % -161.53 %
RGRX's Overall Ranking # 4725 # 4641 # 4265 # 0 # 0
Seq. Investment Change TTM - -56.41 % -37.05 % -28.9 % 19.86 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -2 -2 -2 -2 -2

RGRX Company Profile >> Back to RGRX Roi Comparisons >> See Annual RGRX Return On Investment



Return On Investment RGRX's Ranking
Within: No.
Industry # 424
Sector # 886
Overall # 4725

Return On Investment Statistics
High Average Low
-55.22 %
-310.38 %
-2667.9 %
(Mar 31 2022)   (Dec 31 2018)







Financial Statements
Regenerx Biopharmaceuticals Inc's I. Quarter Investments $ -2 Millions RGRX's Balance sheet
Regenerx Biopharmaceuticals Inc's I. Quarter Income $ 0 Millions Quarterly RGRX's Income Statement
RGRX's Income by Division See RGRX's Income by Division


RGRX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 0 1 0 -2 0
Y / Y Investment Growth - 461.85 % - - -
Net Income in Millions -2 -2 -2 -1 -2
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -186.86 % -1000.98 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGRX's Competitors
Subscribers only: Roi for Regenerx Biopharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for RGRX's Customers

Other Ratios
RGRX's Roa RGRX's Inventory Turnover Ratio RGRX's Growth Rates RGRX's Dividend Statistics
RGRX's Profitability Ratios RGRX's Asset Turnover Ratio RGRX's Dividend Growth
RGRX's Roe RGRX's Valuation Ratios RGRX's Financial Strength Ratios RGRX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Legacy Ventures International Inc  1,092.63 %
Inhibitor Therapeutics Inc   233.77 %
Theravance Biopharma inc   216.05 %
Ir med Inc   161.15 %
Talphera Inc   131.40 %
Molecular Templates Inc   130.08 %
Gyre Therapeutics Inc   101.97 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.